Ex vivo isolation, expansion and bioengineering of CCR7+CD95-/or CD62L+CD45RA+ tumor infiltrating lymphocytes from acute myeloid leukemia patients’ bone marrow

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)1252-1260
Number of pages9
JournalNeoplasia (United States)
Volume23
Issue number12
DOIs
StatePublished - Dec 2021

ASJC Scopus Subject Areas

  • Cancer Research

Keywords

  • Acute myeloid leukemia
  • Adoptive cell therapy
  • Bone marrow
  • CAR-T
  • CCR7
  • CD45RA
  • CD62L
  • CD95
  • Immunotherapy
  • Interleukin
  • Naïve T
  • PD-1
  • Programmed cell death protein 1
  • Tumor-Infiltrating Lymphocytes
  • Leukemia, Myeloid, Acute/immunology
  • Receptors, CCR7/immunology
  • Humans
  • Middle Aged
  • Male
  • fas Receptor/immunology
  • Leukocyte Common Antigens/immunology
  • Lymphocytes, Tumor-Infiltrating/immunology
  • Heterografts
  • T-Lymphocyte Subsets/immunology
  • Adult
  • Female
  • L-Selectin/immunology
  • Bioengineering/methods
  • Animals
  • Bone Marrow Cells/immunology
  • Aged
  • Cell Separation/methods
  • Mice
  • Adoptive Transfer/methods

Cite this